Your browser doesn't support javascript.
loading
Growth dynamics of incidental meningiomas: A prospective long-term follow-up study.
Strømsnes, Torbjørn Austveg; Lund-Johansen, Morten; Skeie, Geir Olve; Eide, Geir Egil; Behbahani, Maziar; Skeie, Bente Sandvei.
Affiliation
  • Strømsnes TA; Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway.
  • Lund-Johansen M; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Skeie GO; Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway.
  • Eide GE; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Behbahani M; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Skeie BS; Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway.
Neurooncol Pract ; 10(3): 238-248, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37188168
ABSTRACT

Background:

There is no consensus on the management of incidental meningiomas. The literature on long-term growth dynamics is sparse and the natural history of these tumors remains to be illuminated.

Methods:

We prospectively assessed long-term tumor growth dynamics and survival rates during active monitoring of 62 patients (45 female, mean age 63.9 years) harboring 68 tumors. Clinical and radiological data were obtained every 6 months for 2 years, annually until 5 years, then every second year.

Results:

The natural progression of incidental meningiomas during 12 years of monitoring was growth (P < .001). However, mean growth decelerated at 1.5 years and became insignificant after 8 years. Self-limiting growth patterns were seen in 43 (63.2%) tumors, non-decelerating in 20 (29.4%) and 5 (7.4%) were inconclusive due to  ≤ 2 measurements. Decelerating growth persisted once established. Within 5 years, 38 (97.4%) of 39 interventions were initiated. None developed symptoms prior to intervention. Large tumors (P < .001) involving venous sinuses (P = .039) grew most aggressively. Since inclusion 19 (30.6%) patients have died of unrelated causes and 2 (3%) from grade 2 meningiomas.

Conclusion:

Active monitoring seems a safe and appropriate first-line management of incidental meningiomas. Intervention was avoided in  > 40% with indolent tumors in this cohort. Treatment was not compromised by tumor growth. Clinical follow-up seems sufficient beyond 5 years if self-limiting growth is established. Steady or accelerating growth warrant monitoring until they reach a stable state or intervention is initiated.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Neurooncol Pract Year: 2023 Document type: Article Affiliation country: Norway

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Neurooncol Pract Year: 2023 Document type: Article Affiliation country: Norway
...